Navalit (Doxylamine Hydrogen Succinate, Pyridoxine Hydrochloride)

Doxylamine hydrogen succinate blocks H1 histamine receptors in the central nervous system, reducing vestibular stimulation that contributes to nausea. This antihistaminic effect, together with pyridoxine’s role as a vitamin B6 cofactor, helps alleviate pregnancy‑related nausea.

The dosage of Navalit is determined by the prescribing clinician based on the individual’s clinical condition, severity of symptoms, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Navalit is specifically formulated for use in pregnancy and is considered safe when prescribed by a qualified health professional. Limited data are available for breastfeeding; clinicians should weigh potential benefits against any possible risks before recommending use.

To order Navalit, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Navalit combines an antihistamine with vitamin B6, offering a dual mechanism that can be more effective for some patients than single‑agent therapies such as ondansetron or metoclopramide. Its safety profile in pregnancy is well‑established, making it a preferred first‑line option in many guidelines.

Navalit should be stored at ambient temperature below 25 °C, in the original packaging, protected from moisture and direct light. Keep the product out of reach of children and do not use after the expiry date printed on the label.

Navalit is taken orally, usually with a glass of water. The tablet should be swallowed whole and not crushed or chewed unless otherwise directed by a healthcare professional.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, skin disorders like Stevens‑Johnson syndrome, and neurological events such as seizures or hallucinations. Patients should seek immediate medical attention if they experience any of these symptoms.

Navalit is contraindicated in individuals with known hypersensitivity to doxylamine, pyridoxine, or any excipients in the formulation. It should also be avoided in patients with uncontrolled glaucoma, severe asthma, or urinary retention unless specifically advised by a physician.